Oral extended-release composition

Details for Australian Patent Application No. 2004249211 (hide)

Owner Andrx Pharmaceuticals, LLC

Inventors Nangia, Avinash; Browder, Monte; Li, Boyong

Agent Wrays

Pub. Number AU-A-2004249211

PCT Pub. Number WO2004/112711

Priority 60/478,915 16.06.03 US

Filing date 16 June 2004

Wipo publication date 29 December 2004

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/24 (2006.01) Medicinal preparations characterised by special physical form - Layered or laminated unitary dosage forms

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2004/112711 Priority application(s): WO2004/112711

26 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249213-Drug polymer complexes

2004249202-Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals